|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/397 | |
| A61K 9/08 | |||
| A61K 35/14 | |||
| A61P 35/00 |
| (11) | Number of the document | 3402480 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17738834.5 |
| Date of filing the European patent application | 2017-01-11 | |
| (97) | Date of publication of the European application | 2018-11-21 |
| (45) | Date of publication and mention of the grant of the patent | 2021-03-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/012948 |
| Date | 2017-01-11 |
| (87) | Number | WO 2017/123593 |
| Date | 2017-07-20 |
| (30) | Number | Date | Country code |
| 201662277236 P | 2016-01-11 | US |
| (72) |
ORONSKY, Bryan, T., US
SCICINSKI, Jan, US
CAROEN, Scott, US
|
| (73) |
EpicentRx, Inc.,
11099 North Torrey Pines Road Suite 160, La Jolla, California 92037,
US
|
| (54) | COMPOSITIONS AND METHODS FOR INTRAVENOUS ADMINISTRATION OF 2-BROMO-1-(3,3-DINITROAZETIDIN-1-YL)ETHANONE |
| COMPOSITIONS AND METHODS FOR INTRAVENOUS ADMINISTRATION OF 2-BROMO-1-(3,3-DINITROAZETIDIN-1-YL)ETHANONE |